BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Acevedo J, Fernández J. New determinants of prognosis in bacterial infections in cirrhosis. World J Gastroenterol 2014; 20(23): 7252-7259 [PMID: 24966596 DOI: 10.3748/wjg.v20.i23.7252]
URL: https://www.wjgnet.com/1007-9327/full/v20/i23/7252.htm
Number Citing Articles
1
Tirdad T. Zangeneh, Razan El Ramahi, Stephen A. Klotz. Zakim and Boyer's Hepatology2018; : 579 doi: 10.1016/B978-0-323-37591-7.00040-9
2
Paulo Lisboa Bittencourt, Carlos Terra, Edison Roberto Parise, Alberto Queiroz Farias, Vincent Arroyo, Javier Fernandez, Gustavo Pereira, Luiz Marcelo Maubouisson, Guilherme Marques Andrade, Fernando Gomes de Barros Costa, Liana Codes, Antônio Ricardo Andrade, Angelo Matos, André Torres, Fernanda Couto, Ivan Zyngier. Intensive care management of patients with liver disease: proceedings of a single-topic conference sponsored by the Brazilian Society of HepatologyArquivos de Gastroenterologia 2015; 52(suppl 1): 55 doi: 10.1590/s0004-28032015000500004
3
Manuela Merli, Cristina Lucidi, Vincenza Di Gregorio, Barbara Lattanzi, Valerio Giannelli, Michela Giusto, Alessio Farcomeni, Giancarlo Ceccarelli, Marco Falcone, Oliviero Riggio, Mario Venditti. An empirical broad spectrum antibiotic therapy in health‐care–associated infections improves survival in patients with cirrhosis: A randomized trialHepatology 2016; 63(5): 1632 doi: 10.1002/hep.28332
4
Juan Acevedo. Multiresistant bacterial infections in liver cirrhosis: Clinical impact and new empirical antibiotic treatment policiesWorld Journal of Hepatology 2015; 7(7): 916-921 doi: 10.4254/wjh.v7.i7.916
5
Kathrine Schmidt Jacobsen, Peter Ott, Peter Lykke Eriksen. Spontaneous bacterial peritonitis – a shift in bacteria and resistance patternScandinavian Journal of Gastroenterology 2019; 54(12): 1499 doi: 10.1080/00365521.2019.1697896
6
Te‐Chun Shen, Chia‐Hung Chen, Hsueh‐Chou Lai, Cheng‐Li Lin, Chih‐Yen Tu, Te‐Chun Hsia, Chuen‐Ming Shih, Wu‐Huei Hsu, Fung‐Chang Sung. Risk of empyema in patients with chronic liver disease and cirrhosis: A nationwide, population‐based cohort studyLiver International 2017; 37(6): 862 doi: 10.1111/liv.13330
7
Wen-Chien Fan, Chia-Chang Huang, Ying-Ying Yang, Alan Lin, Kuei-Chuan Lee, Yun-Cheng Hsieh, Chang-Phone Fung, Hui-Chi Hsu, Ming-Chih Hou, Han-Chieh Lin. Serum pentraxin-3 and tumor necrosis factor-like weak inducer of apoptosis (TWEAK) predict severity of infections in acute decompensated cirrhotic patientsJournal of Microbiology, Immunology and Infection 2017; 50(6): 905 doi: 10.1016/j.jmii.2015.12.006
8
Maria Lagadinou, Charalambos A Gogos. Bacterial infections in cirrhosis patients: a retrospective epidemiologic study in a greek university hospitalClinical Hepatology and Hepatitis Reports 2015; 2(1): 1 doi: 10.7243/2055-088X-2-1
9
Alastair O'Brien, Louise China, Karen A. Massey, Anna Nicolaou, Alison Winstanley, Justine Newson, Adrian Hobbs, Tatsiana Audzevich, Derek W. Gilroy. Bile duct‐ligated mice exhibit multiple phenotypic similarities to acute decompensation patients despite histological differencesLiver International 2016; 36(6): 837 doi: 10.1111/liv.12876
10
Georgios N Kalambokis, Gerasimos Baltayiannis, Dimitrios Christodoulou. von Willebrand factor antigen as a therapeutic target of portal hypertension in cirrhosisWorld Journal of Gastroenterology 2016; 22(19): 4786-4788 doi: 10.3748/wjg.v22.i19.4786
11
Mayank Jain, Joy Varghese, Tom Michael, Chandan Kumar Kedarishetty, Balajee G, Subramanian Swaminathan, Jayanthi Venkataraman. An Insight into Antibiotic Resistance to Bacterial Infection in Chronic Liver DiseaseJournal of Clinical and Experimental Hepatology 2017; 7(4): 305 doi: 10.1016/j.jceh.2017.05.003
12
Louise China, Simon S Skene, Kate Bennett, Zainib Shabir, Roseanna Hamilton, Scott Bevan, Torsten Chandler, Alexander A Maini, Natalia Becares, Derek Gilroy, Ewan H Forrest, Alastair O’Brien. ATTIRE: Albumin To prevenT Infection in chronic liveR failurE: study protocol for an interventional randomised controlled trialBMJ Open 2018; 8(10): e023754 doi: 10.1136/bmjopen-2018-023754
13
Alessandro Risso, Carlo Alessandria, Lavinia Mezzabotta, Chiara Elia, Alida Andrealli, Maurizio Spandre, Paola Di Luigi, Anna Barbui, Andrea Evangelista, Anna Morgando, Roberto Serra, Giovannino Ciccone, Alfredo Marzano, Mario Rizzetto. Adrenal function and microbial DNA in noninfected cirrhotic patients with ascites: Relationship and effect on survivalDigestive and Liver Disease 2015; 47(8): 702 doi: 10.1016/j.dld.2015.04.010
14
Antonios Katsounas, Ali Canbay. Intensive Care Therapy for Patients with Advanced Liver DiseasesVisceral Medicine 2018; 34(4): 283 doi: 10.1159/000492088
15
Tamara Milovanović, Vladimir Nikolić. The influence of bacterial infections on the course and outcome of patients with liver cirrhosis: Prophylaxis and treatmentMedicinska istrazivanja 2017; 51(3): 1 doi: 10.5937/MedIst1703001M
16
Reila Tainá Mendes, Daniel Nguyen, Danielle Stephens, Ferda Pamuk, Daniel Fernandes, Thomas E. Van Dyke, Alpdogan Kantarci, B. A. McCormick. Endothelial Cell Response to Fusobacterium nucleatumInfection and Immunity 2016; 84(7): 2141 doi: 10.1128/IAI.01305-15
17
Louise China, Nicola Muirhead, Simon S Skene, Zainib Shabir, Roel PH De Maeyer, Alexander AN Maini, Derek W Gilroy, Alastair J O'Brien. ATTIRE: Albumin To prevenT Infection in chronic liveR failurE: study protocol for a single-arm feasibility trialBMJ Open 2016; 6(1): e010132 doi: 10.1136/bmjopen-2015-010132
18
Evangelos Cholongitas, Ioannis Goulis, Eirini Pagkalidou, Anna B. Haidich, Apostolos K.A. Karagiannis, Theodora Nakouti, Chrysoula Pipili, Theodora Oikonomou, Spyros Gerou, Evangelos Akriviadis. Relative Adrenal Insufficiency is Associated with the Clinical Outcome in Patients with Stable Decompensated CirrhosisAnnals of Hepatology 2017; 16(4): 584 doi: 10.5604/01.3001.0010.0298